CHELSEA TRASK: Open Payments
NPI 1346748365 · TIGARD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 14 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $397 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| ABBVIE INC. | 4 | $76 |
| UCB, Inc. | 3 | $61 |
| Janssen Biotech, Inc. | 2 | $37 |
Products named: NEMLUVIO, COSENTYX, Bimzelx, SKYRIZI, TREMFYA, RINVOQ, Rhapsido.
Industry payments across OR — which companies pay providers there.
